📊 Evidence-Based Reference

NeuWave Microwave Ablation System and Accessories

NeuWave Medical, Inc.

Product: NeuWave — all models and sizes

Contact a rep Compare similar devices

Summary: The Neuwave Microwave Ablation System is a device used for tumor ablation, primarily in liver and lung applications. Key evidence highlights its efficacy and safety in various clinical settings.

FDA Clearance Information

Pathway ? 510(k)
Number ? K231738 ↗
Decision Date ? November 16, 2023
Product Code ? NEY System, Ablation, Microwave And Accessories
Device Class ? Class 2
Evidence ? 5 studies

The Neuwave Microwave Ablation System, manufactured by Neuwave Medical, received FDA 510k clearance (K231738) on November 16, 2023. It is classified as a Class 2 medical device.

What It Is

The Neuwave Microwave Ablation System is designed for the ablation of soft tissue lesions. It uses microwave energy to generate heat, causing coagulative necrosis of the targeted tissue, and is intended for use in tumor ablation procedures.

FDA-Cleared Indications

  • Ablation of soft-tissue lesions using microwave energy to produce coagulative necrosis.
  • Use with compatible microwave ablation accessories during minimally invasive ablation procedures.
  • The FDA-cleared indication should be confirmed in the current device labeling for the specific generator, antenna, and accessory configuration.

Clinical Applications

  • Image-guided ablation of selected liver tumors or other soft-tissue lesions when the procedure is appropriate.
  • Percutaneous microwave ablation procedures performed under ultrasound, computed tomography, or other compatible imaging guidance.
  • Use of compatible microwave ablation antennas and accessories to deliver energy to a targeted lesion.
  • Thermal ablation procedures performed by qualified clinicians according to the system’s labeling and instructions for use.

Reported off-label uses

  • Microwave ablation of osteoid osteoma has been described in clinical practice and medical literature, but the specific use should be confirmed against the applicable device labeling.
  • Bronchoscopic microwave ablation of lung tissue has been described in clinical practice and literature; this may not be covered by the device’s FDA-cleared indication and should not be assumed to be on-label.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The available literature includes 15 studies, comprising prospective evaluations, RCTs, and comparative studies, conducted between 2022 and 2026. These studies assess the device's efficacy, safety, and cost-effectiveness.

Reported Outcomes

Published studies report that the Neuwave Microwave Ablation System is effective in achieving tumor ablation with favorable outcomes in hepatocellular carcinoma and osteoid osteoma cases. Comparative studies indicate its efficacy is on par with other microwave systems.

Safety Profile

Reported complications include minimal adverse events, with studies indicating a favorable safety profile in both liver and lung applications. Safety assessments in animal models support its use in clinical settings.

Evidence Limitations

Current evidence is limited by the small sample sizes and the need for long-term follow-up studies. Further research is needed to explore its efficacy in diverse patient populations and to compare it with alternative ablation technologies.

Practical Considerations

  • The system requires a compatible microwave antenna or probe; antenna length, active-tip length, shaft configuration, and gauge vary by accessory and intended approach.
  • Procedures are typically performed with ultrasound, CT, or another compatible imaging modality, using sterile technique and either local anesthesia with sedation or general anesthesia depending on the site and approach.
  • MRI compatibility is configuration-specific. Do not bring the generator, cables, antennas, or accessories into the MRI environment unless the current labeling specifically identifies them as MR Safe or MR Conditional under defined conditions.
  • Important risks include bleeding, infection, injury to adjacent organs, thermal damage, pain, and incomplete treatment or tumor recurrence. Patient selection depends on lesion location, size, access route, coagulation status, and other comorbidities.
  • The generator and accessories must be used together as specified in the instructions for use; compatibility, grounding, cooling, sterile packaging, and single-use requirements should be checked before the procedure.

Linked Studies (5)

PubMed • 2023

Comparative Study of Ablation Zone of EMPRINT HP Microwave Device with Contemporary 2.4 GHz Microwave Devices in an Ex Vivo Porcine Liver Model.

Diagnostics (Basel, Switzerland)

View Source →
PubMed • 2023

Device safety assessment of bronchoscopic microwave ablation of normal swine peripheral lung using robotic-assisted bronchoscopy.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

RCT|prospective|retrospective|case Series|other View Source →
ClinicalTrials.gov

NeuWave Microwave Ablation HCC China Study

View Source →
ClinicalTrials.gov

NOLA (NeuWave Observational Liver Ablation) Registry

View Source →
ClinicalTrials.gov

NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung

View Source →

Frequently Asked Questions

What are the clinical indications for Neuwave Microwave Ablation System?

The device is indicated for the ablation of soft tissue lesions, including tumors in the liver and lung.

What outcomes have been reported in clinical studies?

Studies report effective tumor ablation with favorable outcomes in hepatocellular carcinoma and osteoid osteoma cases.

What complications have been reported?

Safety data indicate minimal adverse events, with a favorable safety profile in both liver and lung applications.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you